Humana's venn is light, but includes Dean Rosen, a lobbyist who has written healthcare legislation. From his bio on his lobbying firm's website:
“A partner at Mehlman Castagnetti Rosen & Thomas, Dean Rosen is one of Washington’s foremost experts on America’s complex health care system—and a master of both the politics and policies that shape it. He has more than two decades experience developing and advancing health policy initiatives on Capitol Hill and in the private sector.
“Prior to joining Mehlman Castagnetti, Rosen held a series of high-level positions in both the private sector and government, including on key committees in both the Senate and House. As the Chief Healthcare Advisor to then-Sen. Majority Leader Bill Frist (R-TN), a leading voice on national medical and health issues, he helped draft and navigate to final passage landmark legislation creating a Medicare prescription drug benefit. Rosen also helped pass patient safety legislation and laws in the wake of the September 11 and bioterrorism attacks in 2001 to ensure that local, state and national public health systems had new authorities and additional resources to respond to future threats.
“Earlier, Rosen served as Staff Director for the Senate Subcommittee on Public Health, Majority Counsel for the House Ways and Means Health Subcommittee and Health Policy Coordinator for the Senate Committee on Labor and Human Resources (now the Senate Health, Education, Labor and Pensions Committee). While at Ways and Means, he played a leading role in crafting the Medicare provisions of the Balanced Budget Act of 1997. At Labor, he was the lead Senate staffer in drafting the Health Insurance Portability and Accountability Act of 1996 (HIPAA).”
In addition to Humana, Rosen has lobbied for the following corporations in the healthcare or pharmaceutical industries: Amgen, Vizient, URL Mutual, AstraZeneca, Amyin, Center for Preventative Medicine, Faster Cures, Marathon Pharmaceuticals, Armedica, JSA Health Telepsychiatry, Bluestone Physician Services, Valeant Pharmaceutical, the American Board of Internal Medicine, PhRMA trade association, and the Health Insurance Association of America.
Humana recently left the America's Health Insurance Plans trade association (lobby). Speculation back in January was that this move was an effort to trim costs as it looks for a merger partner. Just recently it was reported that Walmart is considering a partnership deal with Humana. According to the Wall Street Journal, the two entities are in early talks regarding a merger, but there is no guarantee anything will result.
